所有产品
  • 抗体
  • 试剂盒
  • 多肽
  • 探针
  • 蛋白
  • 生化试剂
  • 组织芯片
EN
cAMP/ cGMP/ Protein A/ β-Actin/ BSA/ Ddx4/ APOE/ TAU pT181/ TAU pT217/ Tau 1-441/ Aβ1-40/ Aβ1-42/ α-Syn/ GFAP/ IL/ CD/ 标记试剂盒/ GFP/ Flag/ 多肽合成服务/ /
乳腺
当前位置：首页 > 组织芯片 > 乳腺 > 乳腺
组织芯片
乳腺癌，228例，228芯 （1.1mm）
  • 货号： BRC2281
  • 芯片名称： 乳腺癌，228例，228芯 （1.1mm）
  • 芯片描述： 乳腺癌组织芯片，228例，228芯，包括8例包括正常/良性以及220例癌，提供病理分级，TNM分期及AR，ER，PR，HER2，P53，EGFR，Ki67 IHC数据。
定制服务咨询
详细相关信息
武汉天德生物病理生物芯片系列-BRC2281
芯片编号 BRC2281
芯片名称 乳腺癌，228例，228芯 （1.1mm）
芯片说明 乳腺癌组织芯片，228例，228芯，包括8例包括正常/良性以及220例癌，提供病理分级，TNM分期及AR，ER，PR，HER2，P53，EGFR，Ki67 IHC数据
点数: 228芯
例数: 228例
组织固定方式: 福尔马林固定24h
QA/QC: HE染色和IHC染色
应用: 常规组织学操作包括免疫组织化学(IHC)和原位杂交(ISH)，可以在我们的技术支持页面找到操作流程。
注意事项: 1.收到产品后请常温保存，并在24个月内使用，2.请在实验前60°烤片30分钟，3.请选择温和的修复方式，以免造成组织脱落。
                       
Array Name Array position Order Sex Age Anatomic site Pathology  Nature Grade Stage (TNM) Intensity_Percentage index Percentage
BRC2281A A01 1 F 22 Breast Normal Normal 　 　 0 　
BRC2281A A02 2 F 49 Breast Fibrocystic changes Benign 　 　 0 　
BRC2281A A03 3 F 45 Breast Fibrocystic changes Benign 　 　 - 　
BRC2281A A04 4 F 38 Breast Fibrocystic changes Benign 　 　 1 5%
BRC2281A A05 5 F 43 Breast Fibroadenoma Benign 　 　 0 　
BRC2281A A06 6 F 29 Breast Fibroadenoma Benign 　 　 0 　
BRC2281A A07 7 F 23 Breast Fibroadenoma Benign 　 　 0 　
BRC2281A A08 8 F 40 Breast Fibrocystic changes Benign 　 　 - 　
BRC2281A A09 9 F 54 Breast Invasive ductal carcinoma  Malignant II T2N0M0 0 　
BRC2281A A10 10 F 53 Breast Invasive lobular carcinoma  Malignant II-III T2N0M0 0 　
BRC2281A A11 11 F 44 Breast Invasive ductal carcinoma  Malignant II T2N1M0 0 　
BRC2281A A12 12 F 58 Breast Invasive ductal carcinoma  Malignant II-III T2N1M0 1 5%
BRC2281A A13 13 F 75 Breast Invasive ductal carcinoma  Malignant II-III T3N0M0 0 　
BRC2281A A14 14 F 43 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 8%
BRC2281A A15 15 F 30 Breast Invasive ductal carcinoma  Malignant II T3N0M0 0 　
BRC2281A A16 16 F 43 Breast Invasive ductal carcinoma  Malignant III T3N0M0 0 　
BRC2281A A17 17 F 37 Breast Invasive ductal carcinoma  Malignant II-III T2N1M0 0  
BRC2281A A18 18 F 61 Breast Invasive ductal carcinoma  Malignant II T1N1M0 0 　
BRC2281A A19 19 F 50 Breast Invasive ductal carcinoma  Malignant II-III T2N1M0 2 15%
BRC2281A B01 20 F 48 Breast Invasive ductal carcinoma  Malignant II T2N0M0 2 25%
BRC2281A B02 21 F 46 Breast Invasive ductal carcinoma  Malignant II-III T3N1M0 2 30%
BRC2281A B03 22 F 60 Breast Invasive ductal carcinoma  Malignant II-III T4N0M0 1 5%
BRC2281A B04 23 F 40 Breast Invasive ductal carcinoma  Malignant II-III T3N1M0 0 　
BRC2281A B05 24 F 60 Breast Invasive ductal carcinoma  Malignant II-III T2N1M0 2.5 50%
BRC2281A B06 25 F 35 Breast Invasive ductal carcinoma  Malignant III T2N0M0 0 　
BRC2281A B07 26 F 56 Breast Invasive ductal carcinoma  Malignant III T2N0M0 3 80%
BRC2281A B08 27 F 37 Breast Invasive ductal carcinoma  Malignant II-III T3N0M0 1 5%
BRC2281A B09 28 F 52 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 5%
BRC2281A B10 29 F 52 Breast Intra-ductal carcinoma Malignant I TisN0M0 1 5%
BRC2281A B11 30 F 58 Breast Invasive ductal carcinoma  Malignant II T2N1M0 0 　
BRC2281A B12 31 F 40 Breast Invasive ductal carcinoma  Malignant II T2N1M0 1 5%
BRC2281A B13 32 F 30 Breast Invasive ductal carcinoma  Malignant III T2N1M0 1 8%
BRC2281A B14 33 F 33 Breast Intra-ductal carcinoma Malignant I TisN0M0 1 8%
BRC2281A B15 34 F 49 Breast Invasive ductal carcinoma  Malignant III T3N0M0 1 8%
BRC2281A B16 35 F 52 Breast Invasive ductal carcinoma  Malignant III T2N1M0 0 　
BRC2281A B17 36 F 58 Breast Invasive ductal carcinoma  Malignant II T2N0M0 0 　
BRC2281A B18 37 F 53 Breast Invasive ductal carcinoma  Malignant II T2N0M0 0 　
BRC2281A B19 38 F 47 Breast Invasive ductal carcinoma  Malignant II T2N2M0 0 　
BRC2281A C01 39 F 59 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 5%
BRC2281A C02 40 F 72 Breast Invasive ductal carcinoma  Malignant II T2N1M0 0 　
BRC2281A C03 41 F 58 Breast Mucinous adenocarcinoma Malignant II T3N1M0 1 8%
BRC2281A C04 42 F 40 Breast Invasive ductal carcinoma  Malignant II T4N1M0 2.5 50%
BRC2281A C05 43 F 36 Breast Invasive lobular carcinoma  Malignant III T2N2M0 0 　
BRC2281A C06 44 F 48 Breast Invasive ductal carcinoma  Malignant II T2N0M0 0 　
BRC2281A C07 45 F 44 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 0 　
BRC2281A C08 46 F 56 Breast Invasive ductal carcinoma  Malignant II T2N0M0 3 70%
BRC2281A C09 47 F 50 Breast Invasive ductal carcinoma  Malignant II T2N1M0 1 5%
BRC2281A C10 48 F 42 Breast Invasive ductal carcinoma  Malignant II T4N1M0 2 35%
BRC2281A C11 49 F 34 Breast Intra-ductal carcinoma Malignant II TisN0M0 2 35%
BRC2281A C12 50 F 50 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 1 8%
BRC2281A C13 51 F 83 Breast Invasive ductal carcinoma  Malignant II T4N0M0 1 8%
BRC2281A C14 52 F 64 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 - 　
BRC2281A C15 53 F 27 Breast Invasive ductal carcinoma  Malignant II-III T1N0M0 0 　
BRC2281A C16 54 F 44 Breast Invasive ductal carcinoma  Malignant II-III T2N1M0 2 35%
BRC2281A C17 55 F 30 Breast Invasive ductal carcinoma  Malignant II T2N0M0 0 　
BRC2281A C18 56 F 58 Breast Invasive ductal carcinoma  Malignant II T3N0M0 2 35%
BRC2281A C19 57 F 58 Breast Invasive ductal carcinoma  Malignant II-III T1N0M0 2.5 50%
BRC2281A D01 58 F 60 Breast Invasive ductal carcinoma  Malignant I-II TisN0M0 2 30%
BRC2281A D02 59 F 40 Breast Invasive ductal carcinoma  Malignant II T2N0M0 2.5 50%
BRC2281A D03 60 F 53 Breast Invasive ductal carcinoma  Malignant II T2N0M0 3 60%
BRC2281A D04 61 F 53 Breast Invasive ductal carcinoma  Malignant II-III T1N0M0 0 　
BRC2281A D05 62 F 58 Breast Invasive ductal carcinoma  Malignant II-III T2N1M0 2 30%
BRC2281A D06 63 F 37 Breast Intra-ductal carcinoma Malignant I-II TisN0M0 2 20%
BRC2281A D07 64 F 33 Breast Intra-ductal carcinoma Malignant I TisN0M0 1 8%
BRC2281A D08 65 F 39 Breast Invasive ductal carcinoma  Malignant II-III T4N0M0 1 8%
BRC2281A D09 66 F 62 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 1 8%
BRC2281A D10 67 F 50 Breast Invasive ductal carcinoma  Malignant III T2N0M0 1 8%
BRC2281A D11 68 F 61 Breast Invasive ductal carcinoma  Malignant III T1N0M0 1 5%
BRC2281A D12 69 F 40 Breast Invasive ductal carcinoma  Malignant II-III T1N0M0 2.5 50%
BRC2281A D13 70 F 38 Breast Invasive ductal carcinoma  Malignant II-III T1N0M0 2 35%
BRC2281A D14 71 F 38 Breast Paget's disease Malignant 　 TisN0M0 1 5%
BRC2281A D15 72 F 58 Breast Invasive ductal carcinoma  Malignant II T4N1M0 1 5%
BRC2281A D16 73 F 37 Breast Invasive ductal carcinoma  Malignant II-III T4N1M0 3 90%
BRC2281A D17 74 F 61 Breast Invasive ductal carcinoma  Malignant II-III T4N1M0 0 　
BRC2281A D18 75 F 41 Breast Intra-ductal carcinoma Malignant I TisN0M0 1 8%
BRC2281A D19 76 F 28 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 8%
BRC2281A E01 77 F 54 Breast Invasive ductal carcinoma  Malignant II T1N0M0 0.5 　
BRC2281A E02 78 F 55 Breast Invasive lobular carcinoma  Malignant II-III T1N0M0 1 5%
BRC2281A E03 79 F 30 Breast Invasive ductal carcinoma  Malignant II T2N1M0 3 60%
BRC2281A E04 80 F 44 Breast Invasive ductal carcinoma  Malignant II-III T3N0M0 1 5%
BRC2281A E05 81 F 45 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 1 5%
BRC2281A E06 82 F 48 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 5%
BRC2281A E07 83 F 43 Breast Invasive ductal carcinoma  Malignant II T2N2M0 1 8%
BRC2281A E08 84 F 47 Breast Invasive ductal carcinoma  Malignant II T2N0M0 0 　
BRC2281A E09 85 F 45 Breast Invasive ductal carcinoma  Malignant II-III T2N1M0 1 5%
BRC2281A E10 86 F 55 Breast Invasive lobular carcinoma  Malignant III T3N1M0 0.5 　
BRC2281A E11 87 F 68 Breast Invasive papillary carcinoma Malignant II T2N0M0 1 5%
BRC2281A E12 88 F 45 Breast Invasive ductal carcinoma  Malignant II-III T1N0M0 2 15%
BRC2281A E13 89 F 49 Breast Invasive ductal carcinoma  Malignant II T2N0M0 0 　
BRC2281A E14 90 F 51 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 5%
BRC2281A E15 91 F 42 Breast Invasive ductal carcinoma  Malignant II T3N0M0 1 5%
BRC2281A E16 92 F 36 Breast Invasive ductal carcinoma  Malignant II-III T4N0M0 1 8%
BRC2281A E17 93 F 48 Breast Invasive ductal carcinoma  Malignant II T2N0M0 0 　
BRC2281A E18 94 F 45 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 5%
BRC2281A E19 95 F 30 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 3 90%
BRC2281A F01 96 F 68 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 1 5%
BRC2281A F02 97 F 36 Breast Invasive ductal carcinoma  Malignant II T3N1M0 0 　
BRC2281A F03 98 F 60 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 8%
BRC2281A F04 99 F 44 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 0.5 　
BRC2281A F05 100 F 38 Breast Invasive ductal carcinoma  Malignant III T2N0M0 1 8%
BRC2281A F06 101 F 33 Breast Invasive lobular carcinoma  Malignant III T4N0M0 1 8%
BRC2281A F07 102 F 53 Breast Invasive ductal carcinoma  Malignant II-III T4N0M0 2 25%
BRC2281A F08 103 F 43 Breast Adenoid cystic carcinoma Malignant I-II T2N0M0 1 5%
BRC2281A F09 104 F 42 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 0 　
BRC2281A F10 105 F 50 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 3 60%
BRC2281A F11 106 F 67 Breast Invasive ductal carcinoma  Malignant II T2N0M0 3 60%
BRC2281A F12 107 F 49 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 1 8%
BRC2281A F13 108 F 41 Breast Intra-ductal carcinoma Malignant I TisN0M0 - 　
BRC2281A F14 109 F 41 Breast Mucinous adenocarcinoma Malignant 　 T2N0M0 1 5%
BRC2281A F15 110 F 41 Breast Invasive ductal carcinoma  Malignant II T2N0M0 0 　
BRC2281A F16 111 F 46 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 1 5%
BRC2281A F17 112 F 68 Breast Invasive ductal carcinoma  Malignant II-III T3N0M0 1 5%
BRC2281A F18 113 F 49 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 5%
BRC2281A F19 114 F 62 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 - 　
BRC2281A G01 115 F 44 Breast Invasive ductal carcinoma  Malignant II T3N1M0 2 25%
BRC2281A G02 116 F 60 Breast Invasive ductal carcinoma  Malignant II-III T2N1M0 1 5%
BRC2281A G03 117 F 43 Breast Invasive ductal carcinoma  Malignant III T3N1M0 2 20%
BRC2281A G04 118 F 37 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 5%
BRC2281A G05 119 F 41 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 2 25%
BRC2281A G06 120 F 56 Breast Mucinous adenocarcinoma Malignant 　 T1N0M0 0 　
BRC2281A G07 121 F 41 Breast Invasive ductal carcinoma  Malignant II-III T3N1M0 1 5%
BRC2281A G08 122 F 56 Breast Invasive lobular carcinoma  Malignant II-III T2N0M0 1 5%
BRC2281A G09 123 F 79 Breast Invasive ductal carcinoma  Malignant II T2N0M0 2 30%
BRC2281A G10 124 F 57 Breast Invasive ductal carcinoma  Malignant II T2N0M0 2.5 50%
BRC2281A G11 125 F 54 Breast Invasive lobular carcinoma  Malignant III T3N1M0 2 40%
BRC2281A G12 126 F 33 Breast Invasive ductal carcinoma  Malignant II-III T4N2M0 1 8%
BRC2281A G13 127 F 42 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 0 　
BRC2281A G14 128 F 66 Breast Invasive ductal carcinoma  Malignant II T1N0M0 0 　
BRC2281A G15 129 F 60 Breast Invasive ductal carcinoma  Malignant II T3N1M0 0 　
BRC2281A G16 130 F 45 Breast Invasive ductal carcinoma  Malignant II T3N1M0 0.5 　
BRC2281A G17 131 F 74 Breast Invasive ductal carcinoma  Malignant II-III T1N0M0 1 8%
BRC2281A G18 132 F 38 Breast Invasive ductal carcinoma  Malignant II T1N0M0 1 5%
BRC2281A G19 133 F 58 Breast Invasive ductal carcinoma  Malignant II T1N0M0 1 5%
BRC2281A H01 134 F 57 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 5%
BRC2281A H02 135 F 55 Breast Invasive ductal carcinoma  Malignant III T3N0M0 2 20%
BRC2281A H03 136 F 47 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 1 5%
BRC2281A H04 137 F 46 Breast Invasive ductal carcinoma  Malignant II T2N0M0 0.5 　
BRC2281A H05 138 F 54 Breast Invasive ductal carcinoma  Malignant II-III T3N1M0 1 8%
BRC2281A H06 139 F 52 Breast Invasive ductal carcinoma  Malignant II T2N0M0 0 　
BRC2281A H07 140 F 49 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 5%
BRC2281A H08 141 F 52 Breast Invasive lobular carcinoma  Malignant II-III T2N0M0 0.5 　
BRC2281A H09 142 F 45 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 0 　
BRC2281A H10 143 F 42 Breast Invasive ductal carcinoma  Malignant II T2N0M0 0 　
BRC2281A H11 144 F 48 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 0 　
BRC2281A H12 145 F 44 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 1 8%
BRC2281A H13 146 F 67 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 - 　
BRC2281A H14 147 F 63 Breast Invasive ductal carcinoma  Malignant II T2N0M0 0 　
BRC2281A H15 148 F 44 Breast Invasive ductal carcinoma  Malignant III T2N0M0 1 5%
BRC2281A H16 149 F 46 Breast Invasive ductal carcinoma  Malignant III T2N0M0 3 90%
BRC2281A H17 150 F 34 Breast Invasive lobular carcinoma  Malignant III T2N1M0 0 　
BRC2281A H18 151 F 53 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 0 　
BRC2281A H19 152 F 25 Breast Lobular carcinoma in situ Malignant II TisN0M0 1 5%
BRC2281A I01 153 F 45 Breast Invasive lobular carcinoma  Malignant II-III T2N0M0 - 　
BRC2281A I02 154 F 44 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 0 　
BRC2281A I03 155 F 38 Breast Intra-ductal carcinoma Malignant II T2N0M0 1 5%
BRC2281A I04 156 F 70 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 5%
BRC2281A I05 157 F 56 Breast Invasive ductal carcinoma  Malignant II T3N1M0 0 　
BRC2281A I06 158 F 77 Breast Lipid-rich carcinoma Malignant II T1N0M0 1 8%
BRC2281A I07 159 F 52 Breast Intra-ductal carcinoma Malignant I-II TisN0M0 0 　
BRC2281A I08 160 F 68 Breast Invasive ductal carcinoma  Malignant II-III T1N0M0 1 8%
BRC2281A I09 161 F 68 Breast Invasive ductal carcinoma  Malignant II-III T3N1M0 0 　
BRC2281A I10 162 F 46 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 1 5%
BRC2281A I11 163 F 52 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 0.5 　
BRC2281A I12 164 F 59 Breast Invasive ductal carcinoma  Malignant II-III T3N1M0 2 25%
BRC2281A I13 165 F 39 Breast Invasive ductal carcinoma  Malignant II-III T2N1M0 1 5%
BRC2281A I14 166 F 40 Breast Invasive ductal carcinoma  Malignant II-III T2N1M0 1 5%
BRC2281A I15 167 F 40 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 8%
BRC2281A I16 168 F 60 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 0 　
BRC2281A I17 169 F 50 Breast Invasive papillary carcinoma Malignant 　 T1N0M0 1 5%
BRC2281A I18 170 F 46 Breast Mucinous adenocarcinoma Malignant 　 T2N1M0 1 5%
BRC2281A I19 171 F 39 Breast Invasive ductal carcinoma  Malignant II-III T2N1M0 0 　
BRC2281A J01 172 F 48 Breast Invasive ductal carcinoma  Malignant II-III T1N0M0 2.5 50%
BRC2281A J02 173 F 41 Breast Invasive ductal carcinoma  Malignant II T2N0M0 2 15%
BRC2281A J03 174 F 61 Breast Lobular carcinoma in situ Malignant I-II TisN0M0 - 　
BRC2281A J04 175 F 41 Breast Intra-ductal carcinoma Malignant I-II TisN0M0 2.5 50%
BRC2281A J05 176 F 86 Breast Invasive apocrine carcinoma Malignant III T2N0M0 2 30%
BRC2281A J06 177 F 34 Breast Invasive ductal carcinoma  Malignant II T2N3M0 0 　
BRC2281A J07 178 F 47 Breast Undifferentiated carcinoma Malignant III T2N0M0 0 　
BRC2281A J08 179 F 35 Breast Invasive lobular carcinoma  Malignant III T2N1M0 2.5 50%
BRC2281A J09 180 F 44 Breast Invasive lobular carcinoma  Malignant II T2N1M0 1 5%
BRC2281A J10 181 F 54 Breast Invasive ductal carcinoma  Malignant II-III T1N0M0 3 70%
BRC2281A J11 182 F 58 Breast Invasive ductal carcinoma  Malignant II T2N1M0 0 　
BRC2281A J12 183 F 74 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 5%
BRC2281A J13 184 F 53 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 0 　
BRC2281A J14 185 F 53 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 5%
BRC2281A J15 186 F 48 Breast Invasive ductal carcinoma  Malignant II T2N0M0 1 5%
BRC2281A J16 187 F 43 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 0 　
BRC2281A J17 188 F 34 Breast Intra-ductal carcinoma Malignant I-II TisN0M0 1 8%
BRC2281A J18 189 F 52 Breast Invasive ductal carcinoma  Malignant II T2N0M0 2.5 50%
BRC2281A J19 190 F 40 Breast Invasive ductal carcinoma  Malignant II T2N1M0 0 　
BRC2281A K01 191 F 76 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 3 80%
BRC2281A K02 192 F 39 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 0 　
BRC2281A K03 193 F 52 Breast Invasive ductal carcinoma  Malignant II T2N0M0 2.5 50%
BRC2281A K04 194 F 72 Breast Invasive ductal carcinoma  Malignant II-III T4N0M0 1 8%
BRC2281A K05 195 F 58 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 0 　
BRC2281A K06 196 F 35 Breast Invasive ductal carcinoma  Malignant II T2N0M0 2 15%
BRC2281A K07 197 F 35 Breast Invasive ductal carcinoma  Malignant II T3N1M0 - 　
BRC2281A K08 198 F 60 Breast Invasive ductal carcinoma  Malignant II T2N0M0 - 　
BRC2281A K09 199 F 37 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 1 8%
BRC2281A K10 200 F 53 Breast Invasive ductal carcinoma  Malignant II-III T3N0M0 2 30%
BRC2281A K11 201 F 52 Breast Invasive lobular carcinoma  Malignant II-III T1N0M0 0 　
BRC2281A K12 202 F 62 Breast Invasive ductal carcinoma  Malignant II-III T1N0M0 1 8%
BRC2281A K13 203 F 39 Breast Intra-ductal carcinoma Malignant I TisN0M0 2 35%
BRC2281A K14 204 F 50 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 1 5%
BRC2281A K15 205 F 39 Breast Intra-ductal carcinoma Malignant I-II TisN0M0 1 8%
BRC2281A K16 206 F 64 Breast Invasive ductal carcinoma  Malignant II T3N0M0 0 　
BRC2281A K17 207 F 72 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 1 5%
BRC2281A K18 208 F 78 Breast Mucinous adenocarcinoma Malignant 　 T2N0M0 1 5%
BRC2281A K19 209 F 37 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 3 80%
BRC2281A L01 210 F 42 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 3 70%
BRC2281A L02 211 F 71 Breast Invasive ductal carcinoma  Malignant II T2N0M0 0 　
BRC2281A L03 212 F 33 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 3 70%
BRC2281A L04 213 F 37 Breast Invasive ductal carcinoma  Malignant III T2N0M0 3 80%
BRC2281A L05 214 F 39 Breast Invasive ductal carcinoma  Malignant II T4N1M0 2 20%
BRC2281A L06 215 F 52 Breast Invasive ductal carcinoma  Malignant II T2N0M0 0 　
BRC2281A L07 216 F 50 Breast Invasive ductal carcinoma  Malignant II T2N1M0 - 　
BRC2281A L08 217 F 38 Breast Invasive ductal carcinoma  Malignant II-III T2N1M0 3 80%
BRC2281A L09 218 F 34 Breast Invasive ductal carcinoma  Malignant II-III T2N1M0 1 8%
BRC2281A L10 219 F 62 Breast Intra-ductal carcinoma Malignant I TisN0M0 2 20%
BRC2281A L11 220 F 40 Breast Invasive ductal carcinoma  Malignant II-III T2N1M0 1 5%
BRC2281A L12 221 F 55 Breast Invasive ductal carcinoma  Malignant II-III T2N0M0 2 25%
BRC2281A L13 222 F 44 Breast Invasive ductal carcinoma  Malignant II-III T4N2M0 0 　
BRC2281A L14 223 F 34 Breast Invasive ductal carcinoma  Malignant II-III T2N1M0 2 20%
BRC2281A L15 224 F 72 Breast Invasive ductal carcinoma  Malignant II T2N0M0 2 35%
BRC2281A L16 225 F 82 Breast Mucinous carcinoma Malignant 　 T3N0M0 - 　
BRC2281A L17 226 F 41 Breast Invasive ductal carcinoma  Malignant II T3N1M0 1 5%
BRC2281A L18 227 F 18 Breast Invasive ductal carcinoma  Malignant II-III T2N1M0 2.5 50%
BRC2281A L19 228 F 31 Breast Invasive ductal carcinoma  Malignant II-III T4N1M0 2 35%